Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Glaukos Corporation stock logo
GKOS
Glaukos
$100.20
+3.5%
$94.10
$77.10
$163.71
$5.53B0.8736,047 shs545,646 shs
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$130.88
+2.2%
$134.53
$111.97
$196.26
$3.15B0.88271,437 shs152,831 shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$93.26
+1.0%
$94.54
$82.04
$111.45
$5.46B0.66535,987 shs580,444 shs
Inari Medical, Inc. stock logo
NARI
Inari Medical
$79.97
$79.97
$39.76
$79.99
$4.68B1.021.40 million shsN/A
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Glaukos Corporation stock logo
GKOS
Glaukos
-3.51%-3.51%+0.60%-9.29%-14.35%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
+0.26%-3.88%-0.71%-14.55%+10.31%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
+0.37%-1.55%-3.21%-11.86%+12.30%
Inari Medical, Inc. stock logo
NARI
Inari Medical
0.00%0.00%0.00%0.00%+73.85%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Glaukos Corporation stock logo
GKOS
Glaukos
4.5243 of 5 stars
4.42.00.04.42.12.50.6
ICU Medical, Inc. stock logo
ICUI
ICU Medical
4.5737 of 5 stars
3.53.00.03.92.22.51.9
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
4.1183 of 5 stars
3.51.00.03.82.12.51.3
Inari Medical, Inc. stock logo
NARI
Inari Medical
0.2958 of 5 stars
1.10.00.00.00.02.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Glaukos Corporation stock logo
GKOS
Glaukos
2.75
Moderate Buy$134.6734.40% Upside
ICU Medical, Inc. stock logo
ICUI
ICU Medical
3.00
Buy$192.6747.21% Upside
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
3.00
Buy$109.1117.00% Upside
Inari Medical, Inc. stock logo
NARI
Inari Medical
2.14
Hold$69.22-13.44% Downside

Current Analyst Ratings Breakdown

Latest NARI, MMSI, GKOS, and ICUI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/23/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$106.00 ➝ $110.00
5/21/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$108.00 ➝ $112.00
5/21/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$106.00 ➝ $108.00
5/15/2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$100.00 ➝ $108.00
5/9/2025
ICU Medical, Inc. stock logo
ICUI
ICU Medical
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetStrong-Buy ➝ Strong-Buy$197.00 ➝ $187.00
5/6/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$110.00 ➝ $72.00
5/2/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$140.00 ➝ $115.00
5/1/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$140.00 ➝ $135.00
5/1/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$140.00 ➝ $115.00
5/1/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$176.00 ➝ $115.00
5/1/2025
Glaukos Corporation stock logo
GKOS
Glaukos
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$160.00 ➝ $86.00
(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Glaukos Corporation stock logo
GKOS
Glaukos
$383.48M14.93N/AN/A$13.91 per share7.20
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$2.38B1.35$14.34 per share9.13$80.26 per share1.63
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$1.36B4.06$5.66 per share16.47$23.67 per share3.94
Inari Medical, Inc. stock logo
NARI
Inari Medical
$493.63M9.48$0.09 per share906.95$8.07 per share9.91
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Glaukos Corporation stock logo
GKOS
Glaukos
-$146.37M-$2.37N/AN/AN/A-31.40%-10.66%-8.06%7/30/2025 (Estimated)
ICU Medical, Inc. stock logo
ICUI
ICU Medical
-$117.69M-$3.83N/A24.06N/A-3.87%6.75%3.20%8/6/2025 (Estimated)
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$120.36M$2.0445.7224.873.048.81%15.52%8.72%7/30/2025 (Estimated)
Inari Medical, Inc. stock logo
NARI
Inari Medical
-$1.64M-$1.35N/A727.00N/A-13.68%-10.09%-6.60%N/A

Latest NARI, MMSI, GKOS, and ICUI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$1.23$1.72+$0.49-$0.63$574.15 million$599.49 million
4/30/2025Q1 2025
Glaukos Corporation stock logo
GKOS
Glaukos
-$0.33-$0.22+$0.11-$0.32$102.78 million$106.66 million
4/24/2025Q1 2025
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.75$0.86+$0.11$0.49$352.57 million$355.35 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Glaukos Corporation stock logo
GKOS
Glaukos
N/AN/AN/AN/AN/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
N/AN/AN/AN/AN/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
N/AN/AN/AN/AN/A
Inari Medical, Inc. stock logo
NARI
Inari Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Glaukos Corporation stock logo
GKOS
Glaukos
0.09
6.49
5.62
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.75
2.59
1.52
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.51
4.87
3.26
Inari Medical, Inc. stock logo
NARI
Inari Medical
N/A
1.77
1.40

Institutional Ownership

CompanyInstitutional Ownership
Glaukos Corporation stock logo
GKOS
Glaukos
99.04%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
96.10%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
99.66%
Inari Medical, Inc. stock logo
NARI
Inari Medical
90.98%

Insider Ownership

CompanyInsider Ownership
Glaukos Corporation stock logo
GKOS
Glaukos
6.40%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
1.50%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
3.70%
Inari Medical, Inc. stock logo
NARI
Inari Medical
10.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Glaukos Corporation stock logo
GKOS
Glaukos
78057.14 million53.48 millionOptionable
ICU Medical, Inc. stock logo
ICUI
ICU Medical
15,00024.61 million24.24 millionOptionable
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
7,40059.10 million56.91 millionOptionable
Inari Medical, Inc. stock logo
NARI
Inari Medical
80058.54 million52.34 millionOptionable

Recent News About These Companies

The top nitinol cardiac medtech news of 2025 (so far)
8 spine, orthopedic acquisitions in Q1
Stryker grows cardiovascular division with Inari Medical acquisition
Stryker Completes Acquisition of Inari
Stryker concludes Inari Medical acquisition for $4.9bn
Stryker completes Inari Medical acquisition

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Glaukos stock logo

Glaukos NYSE:GKOS

$100.20 +3.40 (+3.51%)
Closing price 03:59 PM Eastern
Extended Trading
$100.20 +0.00 (+0.00%)
As of 05:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

ICU Medical stock logo

ICU Medical NASDAQ:ICUI

$130.88 +2.81 (+2.19%)
Closing price 04:00 PM Eastern
Extended Trading
$130.84 -0.04 (-0.03%)
As of 04:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Merit Medical Systems stock logo

Merit Medical Systems NASDAQ:MMSI

$93.26 +0.94 (+1.02%)
Closing price 04:00 PM Eastern
Extended Trading
$91.27 -1.99 (-2.13%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Inari Medical stock logo

Inari Medical NASDAQ:NARI

$79.97 0.00 (0.00%)
As of 02/19/2025

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.